SciELO - Scientific Electronic Library Online

 
vol.32 número4Utilidad del suplemento de probioticos (Lactobacillus acidophilus y bulgaricus) en el tratamiento del Síndrome de Intestino IrritableRebrote virológico en el tratamiento de hepatitis B con entecavir: ¿resistencia? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista de Gastroenterología del Perú

versión impresa ISSN 1022-5129

Resumen

BULEJE S, José; YABAR B, Alejandro; GUEVARA-FUJITA, María  y  FUJITA, Ricardo. Molecular and genetic features of gastrointestinal stromal tumors (GIST). Rev. gastroenterol. Perú [online]. 2012, vol.32, n.4, pp.394-399. ISSN 1022-5129.

Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms typically arising in the stomach, small intestine, colon, and other sites in the abdominal cavity and its identification has improved dramatically mainly due to better criteria in its detection. Most GISTs tumors harbor activating mutations in the tyrosine kinase receptor c-KIT or platelet derived growth factor receptor-alpha (PDGFRA). Those mutations are restricted to a few regions corresponding to important functional domains of c-KIT or PDGFRA. Upto 70% of cases are due to mutations in exon 11 of c-KIT corresponding to its juxtamembrane region of the receptor. The location and type of mutation will differentially determine the development of the disease, its prognosis and the response to inhibitors of tyrosine kinases as Imanatib. For this reason, genotyping c-KIT and PDGFRA is important for GIST diagnosis and assessment of sensitivity to tyrosine kinase inhibitors.

Palabras clave : Gastrointestinal stromal tumors; GIST; c-Kit; PDGFRA; Imatinib.

        · resumen en Español     · texto en Español     · Español ( pdf )